Arthritis & Rheumatology News and Research

Latest Arthritis & Rheumatology News and Research

People with asthma or eczema more likely to develop osteoarthritis

Stanford Medicine scientists and their colleagues have found that having asthma or eczema increases the likelihood of developing osteoarthritis — signaling that there may be an allergic pathway that can be targeted with existing drugs.

28 Mar 2023

Forward genetic screening reveals important pathways for sleep regulation in C. elegans

Although the regulation of sleep—how much, when, and how sleep occurs—is mainly considered to be controlled by the brain, sleep deprivation also affects the body, and signals from the body can affect sleep.

27 Mar 2023

Metformin may reduce the risk of osteoarthritis

In a recent study published in JAMA Network Open, researchers in the United States (US) determined the risk of osteoarthritis (OA) and joint replacement among adults with type 2 diabetes (T2D) following metformin or sulfonylurea treatment.

27 Mar 2023

Being ‘socially frail’ comes with health risks for older adults

Consider three hypothetical women in their mid-70s, all living alone in identical economic circumstances with the same array of ailments: diabetes, arthritis, and high blood pressure.

23 Mar 2023

Novel subset of memory B cells predicts long-lived antibody responses to influenza vaccination

Memory B cells play a critical role to provide long-term immunity after a vaccination or infection. In a study published in the journal Immunity, researchers describe a distinct and novel subset of memory B cells that predict long-lived antibody responses to influenza vaccination in humans.

22 Mar 2023

Animal studies show potential of new drug to curb painful hyperinflammation from osteoarthritis

A team of researchers at the Keck School of Medicine of USC have found a drug with the potential for curbing painful hyperinflammation from osteoarthritis, according to results of an animal study.

22 Mar 2023

Avanced genome editing technology could be used as a one-time treatment for CD3 delta SCID

A new UCLA-led study suggests that advanced genome editing technology could be used as a one-time treatment for the rare and deadly genetic disease CD3 delta severe combined immunodeficiency.

21 Mar 2023

Female rheumatoid arthritis patients taking sex hormones have greater chance of achieving remission

A large study of women with rheumatoid arthritis has found that those taking oral contraceptives or hormone replacement therapy (HRT) had a greater chance of achieving remission.

20 Mar 2023

What role does dysbiosis play in Parkinson's disease?

The current study, published in the journal Revue Neurologique, is based on the hypothesis that dysbiosis, or unhealthy variations in the gut and oral microbiota, is a key component of PD pathogenesis.

19 Mar 2023

Decreased viral infection severity in females may be due to extra copy of X chromosome-linked gene

It has long been known that viral infections can be more severe in males than females, but the question as to why has remained a mystery – until possibly now.

17 Mar 2023

Purine metabolite xanthine may play a role in Th17 cell differentiation in the gut

The gut is home to a cast of microbes that influence health and disease. Some types of microorganisms are thought to contribute to the development of inflammatory conditions, such as inflammatory bowel disease (IBD), but the exact cascade of events that leads from microbes to immune cells to disease remains mysterious.

16 Mar 2023

New CDC opioid guidelines: Too little, too late for chronic pain patients?

Jessica Layman estimates she has called more than 150 doctors in the past few years in her search for someone to prescribe opioids for her chronic pain.

15 Mar 2023

New guideline focuses on the timing of hip and knee arthroplasty

The American College of Rheumatology and the American Association of Hip and Knee Surgeons released a summary of its new guideline titled "the Optimal Timing of Elective Hip or Knee Arthroplasty for Patients with Symptomatic Moderate to Severe Osteoarthritis or Osteonecrosis Who Have Failed Nonoperative Therapy."

14 Mar 2023

Long-acting GIPRA inhibits feeding and lowers body weight in mice with diet-induced obesity

The hormone glucose-dependent insulinotropic polypeptide (GIP) is considered obesogenic. In contrast, GIP receptor agonists (GIPRAs) have shown reduced feeding and body weight in an obese mouse model. Therefore, the precise effects exerted by GIP and GIPRAs remain elusive.

14 Mar 2023

Arthritis & Rheumatology News and Research

Latest Arthritis & Rheumatology News and Research

People with asthma or eczema more likely to develop osteoarthritis

Forward genetic screening reveals important pathways for sleep regulation in C. elegans

Metformin may reduce the risk of osteoarthritis

Being ‘socially frail’ comes with health risks for older adults

Novel subset of memory B cells predicts long-lived antibody responses to influenza vaccination

Animal studies show potential of new drug to curb painful hyperinflammation from osteoarthritis

Avanced genome editing technology could be used as a one-time treatment for CD3 delta SCID

Female rheumatoid arthritis patients taking sex hormones have greater chance of achieving remission

What role does dysbiosis play in Parkinson's disease?

Decreased viral infection severity in females may be due to extra copy of X chromosome-linked gene

Purine metabolite xanthine may play a role in Th17 cell differentiation in the gut

New CDC opioid guidelines: Too little, too late for chronic pain patients?

New guideline focuses on the timing of hip and knee arthroplasty

Long-acting GIPRA inhibits feeding and lowers body weight in mice with diet-induced obesity

Study suggests mRNA vaccines decouple SARS-CoV-2 immunity from autoantibody responses observed during acute COVID-19

The burden of Clostridioides difficile infections in the United States

Minimally invasive technique for fixing bunions does not make flatfoot worse, study shows

UB researchers develop new tool to assess the presence and severity of sarcopenia

Feds move to rein in prior authorization, a system that harms and frustrates patients

The 2022 NICE guidelines for the diagnosis and management of gout

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Arthritis & Rheumatology News and Research

Latest Arthritis & Rheumatology News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in